Thoughts on BD1?, page-4

I’d hope we would be hearing something soon as an update should come out by the end of the first quarter as I read it. Probably a few more weeks yet. In response to short and long term. Short term I imagine it will remain volatile with big rises (25-100%) with good announcements and drift back down to hopefully higher support levels as time goes on. Of course a bad announcement and down it goes. I do however hope to see a few good announcements this year so good for long termers as well as day traders. Strong support at much higher levels won’t come until there is a product on the market with a reasonable turnover. In the long term, well how long is a piece of string. If BD-1 ends up with the best tests in the market for 2 or 3 cancers for a considerable time then the sp will soar. I also believe in the directors and don’t expect to see them sit on their laurels so hopefully there will be constant progress with a reasonable r&d in place. Hopefully it will hit the $3 range within the next 5 years but who knows. At this stage though I think there is considerable upside and well worth the investment.